Three convictions, one operating playbook — portable across markets.
We are operators, not investors. The thesis we started with in 2011 is the same thesis we are now carrying into the GCC, Southeast Asia, and Sub-Saharan Africa — one OpCo at a time, with the same platform underneath each.
Doctors are the customer.
We build for the clinician's workflow first. We never insert ourselves between a doctor and a patient, and we do not take a cut of the doctor's revenue.
Last-mile is non-negotiable.
A platform that only works in metros is not a platform for India. MangalCare exists because the digital and the physical have to be designed together.
AI in service of the clinician.
Decision support, automation of admin, and personalisation — used to give clinicians more time, not less, with their patients.
How we expand: the hybrid OpCo model.
We do not enter every market the same way. Each new OpCo is formed via one of three modes, depending on market readiness, regulatory setup, and the quality of available local partners or targets:
- Build. Incubate a new OpCo from scratch — the original LinkedCare and MangalCare playbook, applied to a new market.
- Buy. Acquire an existing local operator with the right clinical reach and integrate them onto our connected-care platform.
- Partner-and-build. Form a joint OpCo with a local operator who takes equity. We contribute platform, capital, and group functions; they contribute clinical reach, local knowledge, and execution.
The mix is deliberate. Some markets will be built from scratch; some will start with an acquisition; some will be joint ventures with a strong local partner. Across all three, the OpCo runs on the same connected-care platform and sits inside the same holding.
Where this is concretely going.
- Gulf States — Saudi Arabia, Qatar, Kuwait, Bahrain, Oman. Building outward from our DIFC base. Strong digital-health readiness and short proximity to HQ.
- Angola and its neighbours — Lusophone-first. Our founder is fluent in Portuguese, LinkedCare started in Portugal in 2011 with >50% MVP market share, and the Portuguese legal entity and network endure. Adjacent Lusophone and neighbouring markets follow Angola.
- Indonesia & the Philippines — ASEAN's two largest healthcare opportunities by population. Fragmented systems, fast digital adoption, and clear demand for connected platforms that respect existing clinical workflows.
Operating posture across all three regions: local on the ground, group at the back. Country teams own commercial, clinical, and partner relationships. The group owns platform, capital, and standards. Each OpCo is local — staff, language, partners — but each runs the same connected patient record underneath.
AI at the core, deliberately.
We treat AI as infrastructure, not as a feature. The goal is to remove administrative burden from clinicians, surface relevant clinical context at the right moment, and personalise patient communication — including reminders, follow-ups, and adherence prompts — in the patient's own language. Every AI capability we ship has a clinician in the loop and a clear audit trail.
How we approach partnerships.
We work with hospitals, multi-specialty groups, individual doctors, NGOs, and government bodies — and increasingly with local operators who want to build the next OpCo with us. We integrate into existing workflows rather than asking partners to abandon what works. Our commercial model is deliberately simple: we charge for the platform, not for the relationships that flow through it.
Trust, privacy, and compliance.
- Patient data ownership and portability are first-class concerns.
- We follow the relevant Indian data protection standards and align with international best practice.
- Clinical data is encrypted in transit and at rest; access is role-based and auditable.
- We do not sell or share patient data with advertisers or third parties.